STOCK TITAN

Tecogen to Participate in Roth Conference in London

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Tecogen Inc. (NYSE American: TGEN), a clean energy products manufacturer, announced its participation in the upcoming 15th Annual Roth Conference in London from June 24-26, 2025. CEO Abinand Rangesh will be available for one-on-one meetings with investors during the event. Interested investors can schedule meetings through their Roth representative or by contacting Tecogen's investor relations via email.
Tecogen Inc. (NYSE American: TGEN), produttore di prodotti per l'energia pulita, ha annunciato la sua partecipazione alla 15ª Conferenza Annuale Roth che si terrà a Londra dal 24 al 26 giugno 2025. Il CEO Abinand Rangesh sarà disponibile per incontri individuali con gli investitori durante l'evento. Gli investitori interessati possono prenotare gli incontri tramite il loro rappresentante Roth o contattando il reparto relazioni con gli investitori di Tecogen via email.
Tecogen Inc. (NYSE American: TGEN), fabricante de productos de energía limpia, anunció su participación en la próxima 15ª Conferencia Anual Roth en Londres del 24 al 26 de junio de 2025. El CEO Abinand Rangesh estará disponible para reuniones individuales con inversores durante el evento. Los inversores interesados pueden programar reuniones a través de su representante Roth o contactando a las relaciones con inversores de Tecogen por correo electrónico.
청정 에너지 제품 제조업체인 Tecogen Inc. (NYSE American: TGEN)은 2025년 6월 24일부터 26일까지 런던에서 열리는 제15회 연례 Roth 컨퍼런스에 참가한다고 발표했습니다. CEO Abinand Rangesh는 행사 기간 동안 투자자들과 일대일 미팅을 진행할 예정입니다. 관심 있는 투자자들은 Roth 담당자나 Tecogen 투자자 관계 부서에 이메일로 연락하여 미팅을 예약할 수 있습니다.
Tecogen Inc. (NYSE American : TGEN), fabricant de produits d'énergie propre, a annoncé sa participation à la 15e conférence annuelle Roth qui se tiendra à Londres du 24 au 26 juin 2025. Le PDG Abinand Rangesh sera disponible pour des réunions individuelles avec les investisseurs pendant l'événement. Les investisseurs intéressés peuvent planifier des rendez-vous via leur représentant Roth ou en contactant le service des relations investisseurs de Tecogen par e-mail.
Tecogen Inc. (NYSE American: TGEN), ein Hersteller von sauberen Energieprodukten, gab seine Teilnahme an der kommenden 15. jährlichen Roth-Konferenz in London vom 24. bis 26. Juni 2025 bekannt. CEO Abinand Rangesh steht während der Veranstaltung für Einzelgespräche mit Investoren zur Verfügung. Interessierte Investoren können Termine über ihren Roth-Vertreter oder per E-Mail an die Investor Relations von Tecogen vereinbaren.
Positive
  • None.
Negative
  • None.

NORTH BILLERICA, MA / ACCESS Newswire / June 11, 2025 / Tecogen Inc. (NYSE American:TGEN) a leading manufacturer of clean energy products, today announced that Abinand Rangesh, Chief Executive Officer, will participate in the 15th Annual Roth Conference hosted in London, England on June 24th to 26th, 2025. Management will be available for one-on-one meetings during the conference.

Attending investors interested in meeting Dr. Rangesh should contact their Roth representative or email investorrelations@tecogen.com.

About Tecogen

Tecogen designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint. In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel in key markets in North America. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 and other federal securities laws that involve a number of risks and uncertainties. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "project," "target," "potential," "will," "should," "seek," "could," "likely," "may," "pro forma," "anticipate," "continue," or other variations thereof (including their use in the negative), or by discussions of strategies, plans or intentions. All statements, other than statements of historical fact included in this press release regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management are forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.

In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and in our Form 8-K, under "Risk Factors," among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.

Tecogen Media & Investor Relations Contact Information:

Abinand Rangesh, CEO
P: 781-466-6487
E: Abinand.Rangesh@tecogen.com

SOURCE: Tecogen, Inc.



View the original press release on ACCESS Newswire

FAQ

When is Tecogen (TGEN) participating in the Roth Conference 2025?

Tecogen will participate in the 15th Annual Roth Conference in London from June 24-26, 2025.

Who will represent Tecogen at the 2025 Roth Conference in London?

Abinand Rangesh, Tecogen's Chief Executive Officer, will represent the company at the conference.

How can investors meet with Tecogen's CEO at the Roth Conference?

Investors can schedule meetings through their Roth representative or by emailing investorrelations@tecogen.com.

Where is the 15th Annual Roth Conference with Tecogen being held?

The conference is being held in London, England.
Tecogen

NYSE:TGEN

TGEN Rankings

TGEN Latest News

TGEN Stock Data

134.43M
12.47M
47.24%
0.04%
Electrical Equipment & Parts
Air-cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip
Link
United States
NORTH BILLERICA